[Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology].
OBJECTIVE
To provide practical recommendations for evaluation and treatment of osteoporosis associated to endocrine diseases and nutritional conditions.


METHODS
Members of the Bone Metabolism Working Group of the Spanish Society of Endocrinology, a methodologist, and a documentalist.


METHODS
Recommendations were formulated according to the GRADE system (Grading of Recommendations, Assessment, Development, and Evaluation) to describe both the strength of recommendations and the quality of evidence. A systematic search was made in MEDLINE (Pubmed), using the following terms associated to the name of each condition: AND "osteoporosis", "fractures", "bone mineral density", and "treatment". Papers in English with publication date before 18 October 2011 were included. Current evidence for each disease was reviewed by two group members, and doubts related to the review process or development of recommendations were resolved by the methodologist. Finally, recommendations were discussed in a meeting of the Working Group.


CONCLUSIONS
The document provides evidence-based practical recommendations for evaluation and management of endocrine and nutritional diseases associated to low bone mass or an increased risk of fracture. For each disease, the associated risk of low bone mass and fragility fractures is given, recommendations for bone mass assessment are provided, and treatment options that have shown to be effective for increasing bone mass and/or to decreasing fragility fractures are listed.
Sección de Endocrinología, Hospital Rafael Méndez, Murcia, España. rebecarg@yahoo.com
Rebeca
R
Reyes García
Esteban
E
Jódar Gimeno
Antonia
A
García Martín
Manuel
M
Romero Muñoz
José Manuel
JM
Gómez Sáez
Inés
I
Luque Fernández
Mariela
M
Varsavsky
Sonsoles
S
Guadalix Iglesias
Isidoro
I
Cano Rodriguez
María Dolores
MD
Ballesteros Pomar
Alfonso
A
Vidal Casariego
Pedro
P
Rozas Moreno
María
M
Cortés Berdonces
Diego
D
Fernández García
Amparo
A
Calleja Canelas
Mercedes
M
Palma Moya
Guillermo
G
Martínez Díaz-Guerra
José J
JJ
Jimenez Moleón
Manuel
M
Muñoz Torres
D015502:Absorptiometry, Photon; D000465:Algorithms; D000856:Anorexia Nervosa / Q000150:complications / Q000628:therapy; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D048909:Diabetes Complications / Q000175:diagnosis; D019468:Disease Management; D004700:Endocrine System Diseases / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D044342:Malnutrition / Q000150:complications*; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010288:Parenteral Nutrition / Q000009:adverse effects; D011178:Postgastrectomy Syndromes / Q000188:drug therapy; D014807:Vitamin D / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D014807:Vitamin D; D002118:Calcium